Tributary Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-293,369
| Closed | -$12.1M | – | 167 |
|
|
2023
Q2 | $12.1M | Sell |
293,369
-5,584
| -2% | -$269K | 1.08% | 47 |
|
|
2023
Q1 | $17.2M | Buy |
298,953
+11,417
| +4% | +$643K | 1.59% | 27 |
|
|
2022
Q4 | $16.1M | Sell |
287,536
-11,653
| -4% | -$593K | 1.61% | 22 |
|
|
2022
Q3 | $12.7M | Sell |
299,189
-2,844
| -0.9% | -$146K | 1.33% | 36 |
|
|
2022
Q2 | $16.3M | Sell |
302,033
-8,754
| -3% | -$526K | 1.62% | 20 |
|
|
2022
Q1 | $20M | Sell |
310,787
-74,532
| -19% | -$4.91M | 1.58% | 16 |
|
|
2021
Q4 | $25.8M | Sell |
385,319
-22,824
| -6% | -$1.54M | 1.95% | 3 |
|
|
2021
Q3 | $27.9M | Sell |
408,143
-6,435
| -2% | -$455K | 2.16% | 2 |
|
|
2021
Q2 | $28.3M | Sell |
414,578
-12,039
| -3% | -$851K | 2.15% | 4 |
|
|
2021
Q1 | $29.5M | Sell |
426,617
-111,205
| -21% | -$7.53M | 2.3% | 2 |
|
|
2020
Q4 | $34.9M | Buy |
537,822
+23,517
| +5% | +$1.27M | 2.5% | 1 |
|
|
2020
Q3 | $24.3M | Sell |
514,305
-28,036
| -5% | -$1.33M | 2.1% | 6 |
|
|
2020
Q2 | $25.5M | Buy |
542,341
+37,265
| +7% | +$1.83M | 2.18% | 5 |
|
|
2020
Q1 | $22.6M | Buy |
505,076
+28,584
| +6% | +$1.5M | 2.3% | 4 |
|
|
2019
Q4 | $27.8M | Sell |
476,492
-14,112
| -3% | -$840K | 1.94% | 9 |
|
|
2019
Q3 | $29.5M | Sell |
490,604
-17,825
| -4% | -$1.06M | 2.14% | 5 |
|
|
2019
Q2 | $28.4M | Sell |
508,429
-409
| -0.1% | -$21.1K | 2% | 7 |
|
|
2019
Q1 | $28.4M | Buy |
508,838
+119,592
| +31% | +$6.09M | 2.06% | 5 |
|
|
2018
Q4 | $17.6M | Buy |
389,246
+43
| +0% | +$2.36K | 1.61% | 17 |
|
|
2018
Q3 | $25.6M | Buy |
389,203
+326
| +0.1% | +$20.3K | 1.94% | 7 |
|
|
2018
Q2 | $25M | Buy |
388,877
+613
| +0.2% | +$38K | 1.96% | 4 |
|
|
2018
Q1 | $21.5M | Buy |
388,264
+26,469
| +7% | +$1.39M | 1.8% | 8 |
|
|
2017
Q4 | $17.3M | Sell |
361,795
-9,484
| -3% | -$464K | 1.51% | 21 |
|
|
2017
Q3 | $18.7M | Sell |
371,279
-1,046
| -0.3% | -$53.7K | 1.61% | 17 |
|
|
2017
Q2 | $20.3M | Sell |
372,325
-36,635
| -9% | -$1.75M | 1.79% | 6 |
|
|
2017
Q1 | $17.2M | Buy |
408,960
+80,006
| +24% | +$3.42M | 1.68% | 12 |
|
|
2016
Q4 | $14.1M | Buy |
328,954
+22,806
| +7% | +$927K | 1.66% | 10 |
|
|
2016
Q3 | $12.6M | Buy |
306,148
+20,902
| +7% | +$876K | 1.64% | 3 |
|
|
2016
Q2 | $11.4M | Buy |
285,246
+29,924
| +12% | +$1.08M | 1.66% | 3 |
|
|
2016
Q1 | $8.6M | Buy |
255,322
+9,918
| +4% | +$309K | 1.36% | 10 |
|
|
2015
Q4 | $8.32M | Sell |
245,404
-4,272
| -2% | -$134K | 1.38% | 7 |
|
|
2015
Q3 | $7.43M | Sell |
249,676
-3,864
| -2% | -$121K | 1.24% | 17 |
|
|
2015
Q2 | $6.98M | Buy |
253,540
+5,913
| +2% | +$158K | 1.09% | 17 |
|
|
2015
Q1 | $6.24M | Buy |
247,627
+16,612
| +7% | +$393K | 0.98% | 29 |
|
|
2014
Q4 | $5.12M | Buy |
+231,015
| New | +$4.68M | 0.87% | 41 |
|
Other funds holding IART
CB
CIP
Tributary Capital Management's IART Position: Q3 2023 in Review
Tributary Capital Management sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 293,369 shares — an estimated $12.1M sold.
Tributary Capital Management first reported a position in IART in Q4 2014 and held it in 35 quarters. The position peaked at $34.9M in Q4 2020. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.
- Tributary Capital Management reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
- Tributary Capital Management sold 293,369 Integra LifeSciences shares in Q3 2023, an estimated $12.1M.
- Tributary Capital Management first reported a position in Integra LifeSciences in Q4 2014 and held it in 35 quarters.
- Tributary Capital Management's Integra LifeSciences position peaked at $34.9M in Q4 2020.
- 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.
Based on Tributary Capital Management's 13F filing for Q3 2023, filed 11 Oct 2023.